Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00738920 · ClinicalTrials.gov registry record · NA
Self Administered Cognitive Behavior Therapy for Irritable Bowel Syndrome
A NA study, sponsored by State University of New York at Buffalo.
- Completed
- Registry status
- NA
- Development phase
- 436
- Enrollment target
NCT00738920 is a NA study that has completed, run by State University of New York at Buffalo. The registered enrollment target is 436 participants.
The verdict
NCT00738920, a NA study, has completed, sponsored by State University of New York at Buffalo.
- COMPLETED
- Registry status
- NA
- Development phase
- 436 participants
- Enrollment target
Study Summary
The primary goal of the proposed trial is to assess the short- and long-term efficacy of cognitive behavior therapy (CBT) for irritable bowel syndrome using two treatment delivery systems (self administered, therapist administered). Secondary aims seek to specify the conditions under which CBT may (or may not) achieve its effects (moderator questions), why and how these effects are achieved (mediator questions) and at what economic cost. Long term project goals are to develop an effective self-administered behavioral treatment program that can enhance the quality of patient care, improve clinical outcomes, and decrease the economic and personal costs of one of the most prevalent and intractable GI disorders.
Interventions
- BEHAVIORAL Self Administered Cognitive Behavior Therapy
- BEHAVIORAL Therapist Administered Cognitive Behavior Therapy
- BEHAVIORAL Behavioral Education and Supportive Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 436 participants |
| Start Date | 2010-08 |
| Est. Completion | 2017-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00738920
The ClinicalTrials.gov registry entry for NCT00738920 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 436 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Self Administered Cognitive Behavior Therapy is the first listed.
NCT00738920 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00738920 about?
NCT00738920 is a clinical study titled "Self Administered Cognitive Behavior Therapy for Irritable Bowel Syndrome". The primary goal of the proposed trial is to assess the short- and long-term efficacy of cognitive behavior therapy (CBT) for irritable bowel syndrome using two treatment delivery systems (self administered, therapist administered). Secondary aims seek to specify the conditions under which CBT may (...
What is the current status of trial NCT00738920?
This trial is currently completed. It is a NA study. The enrollment target is 436 participants. The study started on 2010-08. Estimated completion is 2017-08-31.
What interventions are being tested in trial NCT00738920?
The interventions under investigation include: Self Administered Cognitive Behavior Therapy (BEHAVIORAL), Therapist Administered Cognitive Behavior Therapy (BEHAVIORAL), Behavioral Education and Supportive Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00738920?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.